At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
LipiFlow +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Meibomian Gland Dysfunction Treatment
In Brief
A clinical study evaluating LipiFlow and Light Based (Sham) Treatment for Meibomian Gland Dysfunction and Dry Eye. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the effectiveness of treatments for Meibomian Gland Dysfunction.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMeibomian Gland Dysfunction, Dry Eye
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartFeb 2020
Primary CompletionMar 2021
TodayJul 2026
First PostedJan 18, 2020
Enrollment StartFeb 26, 2020
Primary CompletionMar 25, 2021
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.5 years ago
Interventions
LipiFlowdevice
Medical device that applies a combination of heat and pressure to the inner eyelid to remove gland obstructions and stagnant gland content
Light Based (Sham) Treatmentdevice
A light based (sham) treatment will be used to compare effectiveness to the LipiFlow treatment.